Rethinking ADHD Podcast

In this video, Jess Brunet, Corina Weir, and Penny Lazell discuss the impact of hormonal fluctuations on ADHD symptoms in women and adolescents.  The panel explores how young women may be referred for anxiety or depression, but assessment can identify underlying neurodivergence. They also discuss how symptoms may change across the menstrual cycle, with falling estrogen coinciding with falling dopamine and triggering a dip in mood and change in symptoms.  Some patients report that ADHD medication feels less effective pre-menstruation, highlighting the importance of tracking symptoms using diaries or apps to identify patterns and support more personalized care. Listen to the full episode: https://bit.ly/4iKATjD Watch the discussion instead: https://bit.ly/3Ux3Cyw

How can ADHD care evolve with patients across life stages while continuing to meet their individual clinical needs?In this episode, Melinda Williams-Willingham, MD, FAAP and Angela C. LaRosa, MD, MSCR explore the importance of continuity of care throughout the ADHD journey. They discuss how clinicians can support patients as their needs change across different life stages, while maintaining care that is both clinically appropriate and individualized for long-term outcomes.The conversation considers what it takes to build more consistent, connected ADHD care that adapts to the individual—not just the stage of life they are in.Watch the full video podcast on YouTube to hear the complete conversation on continuity, individualized care, and the future of long-term ADHD care.▶️ Watch expert discussion: https://bit.ly/4qDjGdQ

How can research and data help make ADHD care more individualized, consistent, and accessible?In this mini episode, the Qbtech team explores how research can drive innovation in ADHD care, from understanding individual treatment responses to supporting therapeutic monitoring in virtual and telehealth settings. The conversation highlights how objective data can help clinicians track change over time, make more informed treatment decisions, and provide greater confidence in whether a patient is on the right path.The team also discusses how remote treatment monitoring could reduce the burden of frequent in-person appointments while helping clinicians better understand individual patient responses and support more personalized ADHD care.Watch the full video podcast on YouTube for the complete conversation on research, innovation, objective data, and the future of virtual ADHD care: https://bit.ly/4qdakWeHost: Danielle Vaeth (Senior Market Development Manager, Qbtech)Guests: Ragini Sanyal (Head of Clinical Research) and Robert Nolen (Clinical Research Manager)Topics covered:–Why both clinical research and real-world evidence are essential for developing new ADHD technologies–How clinician feedback shapes innovation and improves patient care–The development of QbMobile and how smartphone technology could make ADHD testing more accessible–What Qbtech has learned from a global database of more than 1 million ADHD assessments–How remote ADHD treatment monitoring can improve patient access while supporting confident clinical decision-makingWho this is for:Clinicians, pediatricians, psychiatrists, mental health professionals.

Is ADHD testing on a mobile or hand-held device the new thing in innovation and technology?In this mini episode, ADHD experts discuss the evolution of objective ADHD assessment and how technology is slowly but surely moving from hardware to software to mobile technology. What could this mean for the future of ADHD care?The trio discusses Qbtech’s work on QbMobile, including early findings around user acceptance and how mobile technology could make objective assessment more accessible.The conversation also looks at the value of data from more than one million patients, and how large-scale, global datasets can help researchers identify new trends, inform clinicians, shape innovation, and contribute to conversations around healthcare policyWatch the full episode: https://bit.ly/4qdakWeHost: Danielle Vaeth (Senior Market Development Manager, Qbtech)Guests: Ragini Sanyal (Head of Clinical Research) and Robert Nolen (Clinical Research Manager)Topics covered:–Why both clinical research and real-world evidence are essential for developing new ADHD technologies–How clinician feedback shapes innovation and improves patient care–The development of QbMobile and how smartphone technology could make ADHD testing more accessible–What Qbtech has learned from a global database of more than 1 million ADHD assessments–How remote ADHD treatment monitoring can improve patient access while supporting confident clinical decision-makingWho this is for:Clinicians, pediatricians, psychiatrists, mental health professionals.

In this mini episode, Qbtech's medical and research team explores how research provides the evidence needed to develop meaningful healthcare innovation, while new technologies create opportunities for further clinical research. From validating digital health solutions to generating real-world evidence, discover why both are essential for improving patient care and advancing behavioral health.Want the full conversation? Watch the complete video podcast on YouTube for deeper insights into how research and innovation are shaping the future of ADHD assessment and digital health: https://bit.ly/4hcMgAoFeaturing: Danielle Vaeth, Senior Market Development Manager, QbtechRagini Sanyal, Head of Clinical Research, QbtechRobert Nolen, Clinical Research Manager, Qbtech

Accurately tracking ADHD symptoms from a patient’s early life can be challenging, especially if developmental history isn’t properly recorded. In this mini episode, our ADHD experts, Jess Brunet and Penny Lazell discuss what a clinician's responsibility is when gathering a patient's developmental history. For more insights into the ADHD world, check out our complete podcast discography – https://bit.ly/4wlNein

How do successful ADHD clinics attract the right patients while building trust with families?In this bonus episode of the Rethinking ADHD Podcast, Sadaf Hassan, Content Marketing Manager at Qbtech, is joined by Dr. Aaron Dodini to explore how ADHD clinics can grow through ethical marketing, clear patient communication, and a strong digital presence.In this episode, you'll learn:• Why marketing and branding matter for ADHD clinics• How to communicate ADHD services with empathy and clarity• Ways to build trust with prospective patients and families• Common marketing mistakes healthcare providers should avoid• Practical ideas for improving your clinic's digital presenceThis episode complements our guide, Marketing ADHD Services to Patients: A Guide to Branding and Communication Strategy, which explores practical marketing approaches for ADHD providers, including SEO, patient education, testimonials, and digital communications – https://bit.ly/44v8plKGuest: Dr. Aaron DodiniHost: Sadaf Hassan, Content Marketing Manager at Qbtech

Katie Hathaway, Charlotte Coates, and Danielle Vaeth explore how virtual ADHD care and objective testing can help patients become more involved in their own treatment journey. Our experts discuss how virtual care models and tools such as QbCheck can make symptom data more accessible and easier for patients to understand. Helping patients to visualize symptoms as measurable data over time can empower them to become more involved in decisions over their ADHD care.   The panel also considers what the future of virtual ADHD care may look like, including improved provider training, scalable care models, and using technology to support clinicians while preserving personalized care and clinical judgment.  To watch their full podcast, visit: https://bit.ly/4avnNCd